Phase 1 Stomach Cancer Trial, Recruiting NCT06610799 Sponsor: Xiangdong Cheng Condition: Stomach Cancer
Back to Stomach Cancer

Phase 1 Stomach Cancer Trial, Recruiting

NCT06610799
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old (male or female)
  • You have advanced or metastatic stomach cancer or cancer at the junction of the stomach and food pipe that has spread and cannot be removed by surgery, and you have not yet received any systemic treatment for it
  • You have at least one tumour that can be measured on a scan, according to standard guidelines
  • You are generally well enough to carry out light activity and care for yourself (but may not be able to do heavy physical work)
  • Your doctor expects you to live for at least 3 more months

Who may not be able to join:

  • You are pregnant, breastfeeding, or planning to become pregnant before, during, or within 6 months after finishing the study treatment
  • You have active, uncontrolled bleeding or a known condition that causes problems with blood clotting or bleeding
  • You have a history of, or currently have, seizures (fits), cancer that has spread to the brain or spine, pressure on the spinal cord, or cancer affecting the membranes around the brain or spinal cord

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 18523197816

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Xiangdong Cheng
Registry
ClinicalTrials.gov
Start date
15 October 2024
Est. completion
30 June 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Objective response rate (ORR); Disease control rate (DCR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov